BioPharm America will be held for the 11th time in 2018. The event is dedicated to encouraging exchanges between hundreds of executives from venture capital firms, major pharmaceutical companies, academic and research institutions, and biotechnology companies of every size and stage – from start-ups to mature companies. The two-day conference program features presentations by thought leaders and executives from across the life science industry. BioPharm America also has special tracks tailored specifically to the needs of start-ups and young companies, allowing them to make the connections that are vital to their development. Among the German pharmaceutical companies that attend BioPharm America are Bayer HealthCare, Boehringer Ingelheim, and Merck.